A wide range of molecular imaging techniques are available that can provide complementary information to conventional, anatomical imaging for the evaluation of known or suspected bone and soft tissue sarcomas. In particular, positron emission tomography (PET), particularly in the form of hybrid PET/CT technology, offers many potential advantages over current imaging approaches by delineating not only the extent of disease but also the biological heterogeneity that can exist both between and within sarcomas. This review discusses the clinical situations where nuclear medicine techniques can aid in the management of patients with sarcoma. These include biopsy guidance, whole body staging, therapeutic response assessment and evaluation of residual mass lesions after treatment.

Author

Rodney J Hicks, Guy C Toner and Peter F M Choong

Contact Details

Corresponding address:
Rodney J Hicks,
The Centre for Molecular Imaging, The Peter MacCallum Cancer Centre,
12 Cathedral Place,
East Melbourne VIC 2002,
Australia

Reference

ICIS Cancer Imaging Volume 5 Issue 1
DOI: 10.1102/1470-7330.2005.0008

Date Posted

21 June 2005

Print PDF

Size

1.91 MB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	7 seconds
ADSL 512Kb/s (Broadband):	30 seconds
64 Kb/s (ISDN):	4 minutes 3 seconds
33.3 Kb/s (Typical Modem):	7 minutes 48 seconds

Screen PDF

Size

420.85 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	1 second
ADSL 512Kb/s (Broadband):	6 seconds
64 Kb/s (ISDN):	52 seconds
33.3 Kb/s (Typical Modem):	1 minute 41 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.